0
     

Report Added
Report already added
Inactivated Vaccine Market - Global Outlook and Forecast 2021-2027

Inactivated Vaccine Market - Global Outlook and Forecast 2021-2027

This report contains market size and forecasts of Inactivated Vaccine in Global, including the following market information:
Global Inactivated Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Inactivated Vaccine market was valued at 5983.1 million in 2020 and is projected to reach US$ 6775.5 million by 2027, at a CAGR of 3.2% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inactivated Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inactivated Vaccine Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Inactivated Vaccine Market Segment Percentages, By Type, 2020 (%)
Children Inactivated Vaccine
Adult Inactivated Vaccine

China Inactivated Vaccine Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Inactivated Vaccine Market Segment Percentages, By Application, 2020 (%)
Hospital
Medical Center

Global Inactivated Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Inactivated Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Inactivated Vaccine Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Inactivated Vaccine Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
Astellas Pharma(Japan)
CSL Limited(Australia)
Emergent BioSolutions(U.S.)
GlaxoSmithKline(U.K.)
Johnson & Johnson(U.S.)
MedImmune(U.S.)
Merck & Co(U.S.)
Pfizer(U.S.)
Sanofi Pasteur(France)
Serum Institute of India Pvt(India)
1 Introduction to Research & Analysis Reports
1.1 Inactivated Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inactivated Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inactivated Vaccine Overall Market Size
2.1 Global Inactivated Vaccine Market Size: 2021 VS 2027
2.2 Global Inactivated Vaccine Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Inactivated Vaccine Players in Global Market
3.2 Top Global Inactivated Vaccine Companies Ranked by Revenue
3.3 Global Inactivated Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Inactivated Vaccine Companies in Global Market, by Revenue in 2020
3.5 Global Companies Inactivated Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Inactivated Vaccine Players in Global Market
3.6.1 List of Global Tier 1 Inactivated Vaccine Companies
3.6.2 List of Global Tier 2 and Tier 3 Inactivated Vaccine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Inactivated Vaccine Market Size Markets, 2021 & 2027
4.1.2 Children Inactivated Vaccine
4.1.3 Adult Inactivated Vaccine
4.2 By Type - Global Inactivated Vaccine Revenue & Forecasts
4.2.1 By Type - Global Inactivated Vaccine Revenue, 2016-2021
4.2.2 By Type - Global Inactivated Vaccine Revenue, 2022-2027
4.2.3 By Type - Global Inactivated Vaccine Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Inactivated Vaccine Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Medical Center
5.2 By Application - Global Inactivated Vaccine Revenue & Forecasts
5.2.1 By Application - Global Inactivated Vaccine Revenue, 2016-2021
5.2.2 By Application - Global Inactivated Vaccine Revenue, 2022-2027
5.2.3 By Application - Global Inactivated Vaccine Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Inactivated Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Inactivated Vaccine Revenue & Forecasts
6.2.1 By Region - Global Inactivated Vaccine Revenue, 2016-2021
6.2.2 By Region - Global Inactivated Vaccine Revenue, 2022-2027
6.2.3 By Region - Global Inactivated Vaccine Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Inactivated Vaccine Revenue, 2016-2027
6.3.2 US Inactivated Vaccine Market Size, 2016-2027
6.3.3 Canada Inactivated Vaccine Market Size, 2016-2027
6.3.4 Mexico Inactivated Vaccine Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Inactivated Vaccine Revenue, 2016-2027
6.4.2 Germany Inactivated Vaccine Market Size, 2016-2027
6.4.3 France Inactivated Vaccine Market Size, 2016-2027
6.4.4 U.K. Inactivated Vaccine Market Size, 2016-2027
6.4.5 Italy Inactivated Vaccine Market Size, 2016-2027
6.4.6 Russia Inactivated Vaccine Market Size, 2016-2027
6.4.7 Nordic Countries Inactivated Vaccine Market Size, 2016-2027
6.4.8 Benelux Inactivated Vaccine Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Inactivated Vaccine Revenue, 2016-2027
6.5.2 China Inactivated Vaccine Market Size, 2016-2027
6.5.3 Japan Inactivated Vaccine Market Size, 2016-2027
6.5.4 South Korea Inactivated Vaccine Market Size, 2016-2027
6.5.5 Southeast Asia Inactivated Vaccine Market Size, 2016-2027
6.5.6 India Inactivated Vaccine Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Inactivated Vaccine Revenue, 2016-2027
6.6.2 Brazil Inactivated Vaccine Market Size, 2016-2027
6.6.3 Argentina Inactivated Vaccine Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Inactivated Vaccine Revenue, 2016-2027
6.7.2 Turkey Inactivated Vaccine Market Size, 2016-2027
6.7.3 Israel Inactivated Vaccine Market Size, 2016-2027
6.7.4 Saudi Arabia Inactivated Vaccine Market Size, 2016-2027
6.7.5 UAE Inactivated Vaccine Market Size, 2016-2027
7 Players Profiles
7.1 Astellas Pharma(Japan)
7.1.1 Astellas Pharma(Japan) Corporate Summary
7.1.2 Astellas Pharma(Japan) Business Overview
7.1.3 Astellas Pharma(Japan) Inactivated Vaccine Major Product Offerings
7.1.4 Astellas Pharma(Japan) Inactivated Vaccine Revenue in Global (2016-2021)
7.1.5 Astellas Pharma(Japan) Key News
7.2 CSL Limited(Australia)
7.2.1 CSL Limited(Australia) Corporate Summary
7.2.2 CSL Limited(Australia) Business Overview
7.2.3 CSL Limited(Australia) Inactivated Vaccine Major Product Offerings
7.2.4 CSL Limited(Australia) Inactivated Vaccine Revenue in Global (2016-2021)
7.2.5 CSL Limited(Australia) Key News
7.3 Emergent BioSolutions(U.S.)
7.3.1 Emergent BioSolutions(U.S.) Corporate Summary
7.3.2 Emergent BioSolutions(U.S.) Business Overview
7.3.3 Emergent BioSolutions(U.S.) Inactivated Vaccine Major Product Offerings
7.3.4 Emergent BioSolutions(U.S.) Inactivated Vaccine Revenue in Global (2016-2021)
7.3.5 Emergent BioSolutions(U.S.) Key News
7.4 GlaxoSmithKline(U.K.)
7.4.1 GlaxoSmithKline(U.K.) Corporate Summary
7.4.2 GlaxoSmithKline(U.K.) Business Overview
7.4.3 GlaxoSmithKline(U.K.) Inactivated Vaccine Major Product Offerings
7.4.4 GlaxoSmithKline(U.K.) Inactivated Vaccine Revenue in Global (2016-2021)
7.4.5 GlaxoSmithKline(U.K.) Key News
7.5 Johnson & Johnson(U.S.)
7.5.1 Johnson & Johnson(U.S.) Corporate Summary
7.5.2 Johnson & Johnson(U.S.) Business Overview
7.5.3 Johnson & Johnson(U.S.) Inactivated Vaccine Major Product Offerings
7.5.4 Johnson & Johnson(U.S.) Inactivated Vaccine Revenue in Global (2016-2021)
7.5.5 Johnson & Johnson(U.S.) Key News
7.6 MedImmune(U.S.)
7.6.1 MedImmune(U.S.) Corporate Summary
7.6.2 MedImmune(U.S.) Business Overview
7.6.3 MedImmune(U.S.) Inactivated Vaccine Major Product Offerings
7.6.4 MedImmune(U.S.) Inactivated Vaccine Revenue in Global (2016-2021)
7.6.5 MedImmune(U.S.) Key News
7.7 Merck & Co(U.S.)
7.7.1 Merck & Co(U.S.) Corporate Summary
7.7.2 Merck & Co(U.S.) Business Overview
7.7.3 Merck & Co(U.S.) Inactivated Vaccine Major Product Offerings
7.4.4 Merck & Co(U.S.) Inactivated Vaccine Revenue in Global (2016-2021)
7.7.5 Merck & Co(U.S.) Key News
7.8 Pfizer(U.S.)
7.8.1 Pfizer(U.S.) Corporate Summary
7.8.2 Pfizer(U.S.) Business Overview
7.8.3 Pfizer(U.S.) Inactivated Vaccine Major Product Offerings
7.8.4 Pfizer(U.S.) Inactivated Vaccine Revenue in Global (2016-2021)
7.8.5 Pfizer(U.S.) Key News
7.9 Sanofi Pasteur(France)
7.9.1 Sanofi Pasteur(France) Corporate Summary
7.9.2 Sanofi Pasteur(France) Business Overview
7.9.3 Sanofi Pasteur(France) Inactivated Vaccine Major Product Offerings
7.9.4 Sanofi Pasteur(France) Inactivated Vaccine Revenue in Global (2016-2021)
7.9.5 Sanofi Pasteur(France) Key News
7.10 Serum Institute of India Pvt(India)
7.10.1 Serum Institute of India Pvt(India) Corporate Summary
7.10.2 Serum Institute of India Pvt(India) Business Overview
7.10.3 Serum Institute of India Pvt(India) Inactivated Vaccine Major Product Offerings
7.10.4 Serum Institute of India Pvt(India) Inactivated Vaccine Revenue in Global (2016-2021)
7.10.5 Serum Institute of India Pvt(India) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Inactivated Vaccine Market Opportunities & Trends in Global Market
Table 2. Inactivated Vaccine Market Drivers in Global Market
Table 3. Inactivated Vaccine Market Restraints in Global Market
Table 4. Key Players of Inactivated Vaccine in Global Market
Table 5. Top Inactivated Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Inactivated Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Inactivated Vaccine Revenue Share by Companies, 2016-2021
Table 8. Global Companies Inactivated Vaccine Product Type
Table 9. List of Global Tier 1 Inactivated Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inactivated Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Inactivated Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Inactivated Vaccine Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Inactivated Vaccine Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Inactivated Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Inactivated Vaccine Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Inactivated Vaccine Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Inactivated Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Inactivated Vaccine Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Inactivated Vaccine Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Inactivated Vaccine Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Inactivated Vaccine Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Inactivated Vaccine Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Inactivated Vaccine Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Inactivated Vaccine Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Inactivated Vaccine Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Inactivated Vaccine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Inactivated Vaccine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Inactivated Vaccine Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Inactivated Vaccine Revenue, (US$, Mn), 2022-2027
Table 30. Astellas Pharma(Japan) Corporate Summary
Table 31. Astellas Pharma(Japan) Inactivated Vaccine Product Offerings
Table 32. Astellas Pharma(Japan) Inactivated Vaccine Revenue (US$, Mn), (2016-2021)
Table 33. CSL Limited(Australia) Corporate Summary
Table 34. CSL Limited(Australia) Inactivated Vaccine Product Offerings
Table 35. CSL Limited(Australia) Inactivated Vaccine Revenue (US$, Mn), (2016-2021)
Table 36. Emergent BioSolutions(U.S.) Corporate Summary
Table 37. Emergent BioSolutions(U.S.) Inactivated Vaccine Product Offerings
Table 38. Emergent BioSolutions(U.S.) Inactivated Vaccine Revenue (US$, Mn), (2016-2021)
Table 39. GlaxoSmithKline(U.K.) Corporate Summary
Table 40. GlaxoSmithKline(U.K.) Inactivated Vaccine Product Offerings
Table 41. GlaxoSmithKline(U.K.) Inactivated Vaccine Revenue (US$, Mn), (2016-2021)
Table 42. Johnson & Johnson(U.S.) Corporate Summary
Table 43. Johnson & Johnson(U.S.) Inactivated Vaccine Product Offerings
Table 44. Johnson & Johnson(U.S.) Inactivated Vaccine Revenue (US$, Mn), (2016-2021)
Table 45. MedImmune(U.S.) Corporate Summary
Table 46. MedImmune(U.S.) Inactivated Vaccine Product Offerings
Table 47. MedImmune(U.S.) Inactivated Vaccine Revenue (US$, Mn), (2016-2021)
Table 48. Merck & Co(U.S.) Corporate Summary
Table 49. Merck & Co(U.S.) Inactivated Vaccine Product Offerings
Table 50. Merck & Co(U.S.) Inactivated Vaccine Revenue (US$, Mn), (2016-2021)
Table 51. Pfizer(U.S.) Corporate Summary
Table 52. Pfizer(U.S.) Inactivated Vaccine Product Offerings
Table 53. Pfizer(U.S.) Inactivated Vaccine Revenue (US$, Mn), (2016-2021)
Table 54. Sanofi Pasteur(France) Corporate Summary
Table 55. Sanofi Pasteur(France) Inactivated Vaccine Product Offerings
Table 56. Sanofi Pasteur(France) Inactivated Vaccine Revenue (US$, Mn), (2016-2021)
Table 57. Serum Institute of India Pvt(India) Corporate Summary
Table 58. Serum Institute of India Pvt(India) Inactivated Vaccine Product Offerings
Table 59. Serum Institute of India Pvt(India) Inactivated Vaccine Revenue (US$, Mn), (2016-2021)

List of Figures
Figure 1. Inactivated Vaccine Segment by Type
Figure 2. Inactivated Vaccine Segment by Application
Figure 3. Global Inactivated Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Inactivated Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Inactivated Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Inactivated Vaccine Revenue in 2020
Figure 8. By Type - Global Inactivated Vaccine Revenue Market Share, 2016-2027
Figure 9. By Application - Global Inactivated Vaccine Revenue Market Share, 2016-2027
Figure 10. By Region - Global Inactivated Vaccine Revenue Market Share, 2016-2027
Figure 11. By Country - North America Inactivated Vaccine Revenue Market Share, 2016-2027
Figure 12. US Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Inactivated Vaccine Revenue Market Share, 2016-2027
Figure 16. Germany Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 17. France Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Inactivated Vaccine Revenue Market Share, 2016-2027
Figure 24. China Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 28. India Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Inactivated Vaccine Revenue Market Share, 2016-2027
Figure 30. Brazil Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Inactivated Vaccine Revenue Market Share, 2016-2027
Figure 33. Turkey Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Inactivated Vaccine Revenue, (US$, Mn), 2016-2027
Figure 37. Astellas Pharma(Japan) Inactivated Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. CSL Limited(Australia) Inactivated Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Emergent BioSolutions(U.S.) Inactivated Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. GlaxoSmithKline(U.K.) Inactivated Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Johnson & Johnson(U.S.) Inactivated Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. MedImmune(U.S.) Inactivated Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Merck & Co(U.S.) Inactivated Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Pfizer(U.S.) Inactivated Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sanofi Pasteur(France) Inactivated Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Report Title: Inactivated Vaccine Market - Global Outlook and Forecast 2021-2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW